Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 284, Issue 1 47-1, 2003, Pages

  Jaeschke, Hartmut ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Adhesion molecules; Apoptosis; Chemokines; Complement; Cytokines; Kupffer cells; Neutrophils; Nitric oxide; Reactive oxygen

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SELECTIN;

APOPTOSIS; CELL DEATH; COMPLEMENT ACTIVATION; HEAT SHOCK; INFLAMMATION; ISCHEMIA; KUPFFER CELL; LIVER ISCHEMIA; LIVER SURGERY; MICROCIRCULATION; MOLECULAR MECHANICS; MORBIDITY; NEUTROPHIL; OUTCOMES RESEARCH; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; STRESS;

EID: 0037229864     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00342.2002     Document Type: Review

References (181)

1. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, and Diehl AM. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 263: G579-G585, 1992.
2. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Ritter T, Volk HD, Farmer DG, Ghobrial RM, Busuttil RW, and Kupiec-Weglinski JW. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104: 1631-1639, 1999.
3. Amersi F, Dulkanchainun T, Nelson SK, Farmer DG, Kato H, Zaky J, Melinek J, Shaw GD, Kupiec-Weglinski JW, Horwitz LD, Horwitz MA, and Busuttil RW. A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model. Transplantation 71: 112-118, 2001.
4. Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk HD, Busuttil RW, Buelow R, and Kupiec-Weglinski JW. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 35: 815-823, 2002.
5. Arai M, Thurman RG, and Lemasters JJ. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 32:297-302, 2000.
6. Arai M, Thurman RG, and Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: Role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 7: 292-299, 2001.
7. Bajt ML, Farhood A, and Jaeschke H. Effects of CXC chemokines on neutrophil activation and sequestration in the hepatic vasculature. Am J Physiol Gastrointest Liver Physiol 281: G1188-G1195, 2001.
8. Bauer M and Bauer I. Heme oxygenase-1: Redox regulation and role in the hepatic response to oxidative stress. Antiox Redox Signal 4: 749-758, 2002.
9. Bautista AP and Spitzer JJ. Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion. Free Radic Res Commun 17: 195-209, 1992.
10. Bell FP, Essani NA, Manning AM, and Jaeschke H. Ischemia-reperfusion activates the nuclear transcription factor NF-ΚB and upregulates messenger RNA synthesis of adhesion molecules in the liver in vivo. Hepatol Res 8: 178-188, 1997.
11. Bilzer M and Gerbes A. Preservation injury of the liver: Mechanisms and novel therapeutic strategies. J Hepatol 32: 508-515, 2000.
12. Bilzer M, Jaeschke H, Vollmar AM, Paumgartner G, and Gerbes AL. Prevention of Kupffer cell-induced injury in rat liver by atrial natriuretic peptide (ANP): A novel endogenous defense mechanism against oxidant injury. Am J Physiol Gastrointest Liver Physiol 276: G1137-G1144, 1999.
13. Bilzer M and Lauterburg BH. Oxidant stress and potentiation of ischemia-reperfusion injury to the perfused rat liver by human polymorphonuclear leukocytes. J Hepatol 20: 473-477, 1994.
14. Bilzer M, Paumgartner G, and Gerbes AL. Glutathione protects the rat liver against reperfusion injury after hypothermic preservation. Gastroenterology 117: 200-210, 1999.
15. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, and Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: Effects of reperfusion. Hepatology 13: 83-95, 1991.
16. Camargo CA Jr, Madden JF, Gao W, Selvan RS, and Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26: 1513-1520, 1997.
17. Carini R, De Cesaris MG, Splendore R, Vay D, Domenicotti C, Nitti MP, Paola D, Pronzato MA, and Albano E. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology 33: 131-139, 2001.
18. Carini R, Grazia De Cesaris M, Splendore R, and Albano E. Stimulation of p38 MAP kinase reduces acidosis and Na(+) overload in preconditioned hepatocytes. FEBS Lett 491: 180-183, 2000.
19. Chavez-Cartaya RE, DeSola GP, Wright L, Jamieson NV, and White DJ. Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion. Transplantation 59: 1047-1052, 1995.
20. Chosay JG, Essani NA, Dunn CJ, and Jaeschke H. Neutrophil margination and extravasation in sinusoids and venules of the liver during endotoxin-induced injury. Am J Physiol Gastrointest Liver Physiol 272: G1195-G1200, 1997.
21. Chun K, Zhang J, Biewer J, Ferguson D, and Clemens MG. Microcirculatory failure determines lethal hepatocyte injury in ischemic/reperfused rat livers. Shock 1: 3-9, 1994.
22. Clavien PA, Yadav S, Sindram D, and Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232: 155-162, 2000.
23. Colletti LM, Cortis A, Lukacs N, Kunkel SL, Green M, and Strieter RM. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 10: 182-191, 1998.
24. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, and Strieter RM. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 23: 506-514, 1996.
25. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, and Campbell DA Jr. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85: 1936-1943, 1990.
26. Cursio R, Gugenheim J, Ricci JE, Crenesse D, Rostagno P, Maulon L, Saint-Paul MC, Ferrua B, and Auberger AP. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 13: 253-261, 1999.
27. Curzio M, Esterbauer H, Di Mauro C, Cecchini G, and Dianzani MU. Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals. Biol Chem Hoppe Seyler 367: 321-329, 1986.
28. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, and Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 171: 1155-1162, 1990.
29. Elimadi A, Sapena R, Settaf A, Le Louet H, Tillement J, and Morin D. Attenuation of liver normothermic ischemia-reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative. Biochem Pharmacol 62: 509-516, 2001.
30. Essani NA, Bajt ML, Vonderfecht SL, Farhood A, and Jaeschke H. Transcriptional activation of vascular cell adhesion molecule-1 (VCAM-1) gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J Immunol 158: 5941-5948, 1997.
31. Essani NA, Fisher MA, Farhood A, Manning AM, Smith CW, and Jaeschke H. Cytokine-induced hepatic intercellular adhesion molecule-1 (ICAM-1) mRNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology 21: 1632-1639, 1995.
32. Essani NA, Fisher MA, and Jaeschke H. Inhibition of NF-κB by dimethyl sulfoxide correlates with suppression of TNF-α formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 7: 90-96, 1997.
33. Essani NA, Fisher MA, Simmons CA, Hoover JL, Farhood A, and Jaeschke H. Increased P-selectin gene expression in the liver vasculature and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J Leukoc Biol 63: 288-296, 1998.
34. Fan C, Zwacka RM, and Engelhardt JF. Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med 77: 577-592, 1999.
35. Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, and Jaeschke H. Intercellular adhesion molecule-1 (ICAM-1) gene expression and its role in neutrophil-induced ischemia-reperfusion injury in the liver. J Leukoc Biol 57: 368-374, 1995.
36. Fisher MA, Eversole RR, Beuving LJ, and Jaeschke H. Sinusoidal endothelial cell and parenchymal cell injury during endotoxemia and hepatic ischemia-reperfusion: Protection by the 21-aminosteroid tirilazad mesylate. Int Hepatol Commun 6: 121-129, 1997.
37. Fox-Robichaud A and Kubes P. Molecular mechanisms of tumor necrosis factor a-stimulatdd leukocyte recruitment into the murine hepatic circulation. Hepatology 31: 1123-1127, 2000.
38. Garcia-Criado FJ, Toledo-Pereyra LH, Lopez-Neblina F, Phillips ML, Paez-Rollys A, and Misawa K. Role of P-selectin in total hepatic ischemia and reperfusion. J Am Coll Surg 181: 327-334, 1995.
39. Gonzalez-Flecha B, Cutrin JC, and Boveris A. Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J Clin Invest 91: 456-464, 1993.
40. Goto M, Takei Y, Kawano S, Nagano K, Tsuji S, Masuda E, Nishimura Y, Okumura S, Kashiwagi T, Fusamoto H, and Kamada T. Endothelin-1 involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 19: 675-681, 1994.
41. Granger DN and Kubes P. The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55: 662-675, 1994.
42. Grattagliano I, Vendemiale G, and Lauterburg BH. Reperfusion injury of the liver: Role of mitochondria and protection by glutathione ester. J Surg Res 86: 2-8, 1999.
43. Gujral JS, Bucci TJ, Farhood A, and Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: Apoptosis or necrosis? Hepatology 33: 397-405, 2001.
44. Harbrecht BG, Wu B, Watkins SC, Marshall HP Jr, Peitzman AB, and Billiar TR. Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury. Shock 4: 332-337, 1995.
45. Hashikura Y, Kawasaki S, Matsunami H, Ikegami T, and Makuuchi M. Intraoperative increment of platelet-activating factor in clinical liver transplantation. Clin Transplant 8: 27-29, 1994.
46. Hines IN, Harada H, Bharwani S, Pavlick KP, Hoffman JM, and Grisham MB. Enhanced post-ischemic liver injury in iNOS-deficient mice: A cautionary note. Biochem Biophys Res Commun 284: 972-976, 2001.
47. Hines IN, Kawachi S, Harada H, Pavlick KP, Hoffman JM, Bharwani S, Wolf RE, and Grisham MB. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem 234-235: 229-237, 2002.
48. Hisama N, Yamaguchi Y, Ishiko T, Miyanari N, Ichiguchi O, Goto M, Mori K, Watanabe K, Kawamura K, Tsurufuji S, and Ogawa M. Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 24: 1193-1198, 1996.
49. Horie Y, Wolf R, Miyasaka M, Anderson DC, and Granger DN. Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats. Gastroenterology 111: 666-673, 1996.
50. Hsu CM, Wang JS, Liu CH, and Chen LW. Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock 17: 280-285, 2002.
51. Hughes H, Farhood A, and Jaeschke H. The role of leukotriene B4 in the pathogenesis of hepatic ischemia-reperfusion injury in the rat. Prostaglandins Leukot Essent Fatty Acids 45: 113-119, 1992.
52. Jaeschke H. Cellular adhesion molecules: Regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol Gastrointest Liver Physiol 273: G602-G611, 1997.
53. Jaeschke H. Mechanism of reperfusion injury after warm ischemia of the liver. J Hepatol 21: 402-408, 1998.
54. Jaeschke H. Preservation injury: Mechanisms, prevention and consequences. J Hepatol 25: 774-780, 1996.
55. Jaeschke H. Reactive oxygen and ischemia-reperfusion injury of the liver. Chem Biol Interact 79: 115-136, 1991.
56. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 15: 718-724, 2000.
57. Jaeschke H. Reperfusion injury after warm ischemia or cold storage of the liver: Role of apoptotic cell death. Transplant Proc. In press.
58. Jaeschke H. Vascular oxidant stress and hepatic ischemiareperfusion injury. Free Radic Res Commun 12-13: 737-743, 1991.
59. Jaeschke H, Bautista AP, Spolarics Z, and Spitzer JJ. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun 15: 277-284, 1991.
60. Jaeschke H, Bautista AP, Spolarics Z, and Spitzer JJ. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukoc Biol 52: 377-382, 1992.
61. Jaeschke H, Essani NA, Farhood A, and Smith CW. Mechanisms of inflammatory liver injury during ischemia-reperfusion and endotoxemia. In: Cells of the Hepatic Sinusoid. Proceedings of the Eighth International Symposium on Cells of the Hepatic Sinusoid, edited by Wisse E, Knook DL, and Balabaud C. Leiden, The Netherlands: Kupffer Cell Foundation, 1997, vol. 6, p. 158-163.
62. Jaeschke H and Farhood A. Kupffer cell activation after no-flow ischemia versus hemorrhagic shock. Free Radic Biol Med 33: 210-219, 2002.
63. Jaeschke H and Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver in vivo. Am J Physiol Gastrointest Liver Physiol 260: G355-G362, 1991.
64. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, and Spitzer JJ. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol Gastrointest Liver Physiol 264: G801-G809, 1993.
65. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, and Smith CW. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 17: 915-923, 1993.
66. 2 integrins and intercellular adhesion molecule-1. Shock 6: 345-350, 1996.
67. Jaeschke H, Farhood A, and Smith CW. Neutrophils contribute to ischemia-reperfusion injury in rat liver in vivo. FASEB J 4: 3355-3359, 1990.
68. Jaeschke H, Farhood A, and Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 261: G1051-G1056, 1991.
69. Jaeschke H, Fisher MA, Lawson JA, Simmons CA, Farhood A, and Jones DA. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 160: 3480-3486, 1998.
70. Jaeschke H, Ho YS, Fisher MA, Lawson JA, and Farhood A. Glutathione peroxidase deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: Importance of an intracellular oxidant stress. Hepatology 29: 443-450, 1999.
71. Jaeschke H and Mitchell JR. Mitochondria and xanthine oxidase both generate reactive oxygen species after hypoxic damage in isolated perfused rat liver. Biochem Biophys Res Commun 160: 140-147, 1989.
72. Jaeschke H and Smith CW. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 61: 647-653, 1997.
73. Jassem W, Fuggle SV, Rela M, Koo DD, and Heaton ND. The role of mitochondria in ischemia/reperfusion injury. Transplantation 73: 493-499, 2002.
74. Jin FY, Nathan C, Radzioch D, and Ding A. Secretory leukocyte protease inhibitor: A macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88: 417-426, 1997.
75. Kawano K, Kim YI, Ono M, Goto S, Kai T, and Kobayashi M. Evidence that both cyclosporin and azathioprine prevent warm ischemia reperfusion injury to the rat liver. Transpl Int 6: 330-336, 1993.
76. Kim YI, Hwang YJ, Song KE, Yun YK, Lee JW, and Chun BY. Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver. J Am Coll Surg 195: 41-50, 2002.
77. Knight TR, Ho YS, Farhood A, and Jaeschke H. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: Protection by glutathione. J Pharmacol Exp Therap. In press.
78. Kobayashi A, Imamura H, Isobe M, Matsuyama Y, Soeda J, Matsunaga K, and Kawasaki S. Mac-1 (CD11b/CD18) and intercellular adhesion molecule-1 in ischemia-reperfusion injury of rat liver. Am J Physiol Gastrointest Liver Physiol 281: G577-G585, 2001.
79. B-receptor antagonist (Ro-47-0203) on hepatic microcirculation after warm ischemia. Dig Dis Sci 42: 1316-1321, 1997.
80. Kohli V, Selzner M, Madden JF, Bentley RC, and Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 67: 1099-1105, 1999.
81. Koo A, Komatsu H, Tao G, Inoue M, Guth PH, and Kaplowitz N. Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: Evidence for a role for superoxide anion. Hepatology 15: 507-514, 1991.
82. Kubes P, Payne D, and Woodman RC. Molecular mechanisms of leukocyte recruitment in postischemic liver microcirculation. Am J Physiol Gastrointest Liver Physiol 283: G139-G147, 2002.
83. Kumamoto Y, Suematsu M, Shimazu M, Kato Y, Sano T, Makino N, Hirano KI, Naito M, Wakabayashi G, Ishimura Y, and Kitajima M. Kupffer cell-independent acute hepatocellular oxidative stress and decreased bile formation in post-coldischemic rat liver. Hepatology 30: 1454-1463, 1999.
84. Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T, Yagi T, Nakagami M, Takada Y, Morimoto T, and Yamaoka Y. Ischemic preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 128: 251-258, 1996.
85. Kurokawa T, Kobayashi H, Nonami T, Harada A, Nakao A, Sugiyama S, Ozawa T, and Takagi H. Beneficial effects of cyclosporine on postischemic liver injury in rats. Transplantation 53: 308-311, 1992.
86. Kushimoto S, Okajima K, Uchiba M, Murakami K, Harada N, Okabe H, and Takatsuki K. Role of granulocyte elastase in ischemia/reperfusion injury of rat liver. Crit Care Med 24: 1908-1912, 1996.
87. Lawson JA, Burns AR, Farhood A, Bajt ML, Collins RG, Smith CW, and Jaeschke H. Pathophysiological importance of E- and L-selectin for neutrophil-induced liver injury during endotoxemia in mice. Hepatology 32: 990-998, 2000.
88. Leducq N, Delmas-Beauvieux MC, Bourdel-Marchasson I, Dufour S, Gallis JL, Canioni P, and Diolez P. Mitochondrial and energetic dysfunctions of the liver during normothermic reperfusion: Protective effect of cyclosporine and role of the mitochondrial permeability transition pore. Transplant Proc 32: 479-480, 2000.
89. Lee VG, Johnson ML, Baust J, Laubach VE, Watkins SC, and Billiar TR. The roles of iNOS in liver ischemia-reperfusion injury. Shock 16: 355-360, 2001.
90. Lehmann TG, Koeppel TA, Munch S, Heger M, Kirschfink M, Klar E, and Post S. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia. Microvasc Res 62: 284-292, 2001.
91. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, and Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 153: 1778-1788, 1994.
92. Le Moine O, Louis H, Demols A, Desalle F, Demoor F, Quertinmont E, Goldman M, and Deviere J. Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin-10 in mice. Hepatology 31: 1266-1274, 2000.
93. Lentsch AB, Kato A, Yoshidome H, McMasters KM, and Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32: 169-173, 2000.
94. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, and Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC. Hepatology 27: 507-512, 1998.
95. Lentsch AB, Yoshidome H, Kato A, Warner RL, Cheadle WG, Ward PA, and Edwards MJ. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology 30: 1448-1453, 1999.
96. Lentsch AB, Yoshidome H, Warner RL, Ward PA, and Edwards MJ. Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology 117: 953-961, 1999.
97. Li JM and Shah AM. Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase. Cardiovasc Res 52: 477-486, 2001.
98. Li XK, Matin AFM, Suzuki H, Uno T, Yamaguchi T, and Harada Y. Effect of protease inhibitor on ischemia-reperfusion injury of the rat liver. Transplantation 56: 1331-1336, 1993.
99. Lichtman SN and Lemasters JJ. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin Liver Dis 19: 171-187, 1999.
100. Liu P, Fisher MA, Farhood A, Smith CW, and Jaeschke H. Beneficial effects of extracellular glutathione against endotoxin-induced liver injury during ischemia and reperfusion. Circ Shock 43: 64-70, 1994.
101. Liu P, McGuire GM, Fisher MA, Farhood A, Smith CW, and Jaeschke H. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 3: 56-62, 1995.
102. Liu P, Vonderfecht SL, McGuire GM, Fisher MA, Farhood A, and Jaeschke H. The 21-aminosteroid tirilazad mesylate protects in a model of endotoxin shock and acute liver failure in rats. J Pharmacol Exp Ther 271: 438-445, 1994.
103. Liu P, Yin K, Nagele R, and Wong PY. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats. J Pharmacol Exp Ther 284: 1139-1146, 1998.
104. Lloris-Carsi JM, Cejalvo D, Toledo-Pereyra LH, Calvo MA, and Suzuki S. Preconditioning: Effect upon lesion modulation in warm liver ischemia. Transplant Proc 25: 3303-3304, 1993.
105. Maher JJ, Scott MK, Saito JM, and Burton MC. Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 25: 624-630, 1997.
106. Manjo G and Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3-15, 1995.
107. Maroushek-Boury N and Czyprynski CJ. Listeria monocytogenes infection increases neutrophil adhesion and damage to a murine hepatocyte cell line in vitro. Immunol Lett 46: 111-116, 1995.
108. Martinez-Mier G, Toledo-Pereyra LH, McDuffie JE, Warner RL, and Ward PA. P-selectin and chemokine response after liver ischemia and reperfusion. J Am Coll Surg 191: 395-402, 2000.
109. Mathews WR, Guido DM, Fisher MA, and Jaeschke H. Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia. Free Radic Biol Med 16: 763-770, 1994.
110. Mavier P, Preaux AM, Guigui B, Lescs MC, Zafrani ES, and Dhumeaux D. In vitro toxicity of polymorphonuclear neutrophils to rat hepatocytes: Evidence for a proteinase-mediated mechanism. Hepatology 8: 254-258, 1988.
111. McCurry KR, Campbell DA Jr, Scales WE, Warren JS, and Remick DG. Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J Surg Res 55: 49-54, 1993.
112. McCuskey RS. Morphological mechanisms for regulating blood flow through hepatic sinusoids. Liver 20: 3-7, 2000.
113. McCuskey RS, Urbaschek R, and Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res 32: 752-763, 1996.
114. McKeown CM, Edwards V, Phillips MJ, Harvey PR, Petrunka CN, and Strasberg SM. Sinusoidal lining cell damage: The critical injury in cold preservation of liver allografts in the rat. Transplantation 46: 178-191, 1988.
115. Meguro M, Katsuramaki T, Nagayama M, Kimura H, Isobe M, Kimura Y, Matsuno T, Nui A, and Hirata K. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation 73: 1439-1446, 2002.
116. Menger MD and Vollmar B. Role of microcirculation in transplantation. Microcirculation 7: 291-306, 2000.
117. Ming Z, Han C, and Lautt WW. Nitric oxide mediates hepatic arterial vascular escape from norepinephrine-induced constriction. Am J Physiol Gastrointest Liver Physiol 277: G1200-G1206, 1999.
118. Nagendra AR, Mickelson JK, and Smith CW. CD18 integrin and CD54-dependent neutrophil adhesion to cytokine-stimulated human hepatocytes. Am J Physiol Gastrointest Liver Physiol 272: G408-G416, 1997.
119. Nakamura S, Nishiyama R, Serizawa A, Yokoi Y, Suzuki S, Konno H, Baba S, and Muro H. Hepatic release of endothelin-1 after warm ischemia. Transplantation 59: 679-684, 1995.
120. 2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 126: 945-954, 1999.
121. Nieminen AL, Byrne AM, Herman B, and Lemasters JJ. Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am J Physiol Cell Physiol 272: C1286-C1294, 1997.
122. Nieminen AL, Saylor AK, Tesfai SA, Herman B, and Lemasters JJ. Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. Biochem J 307: 99-106, 1995.
123. Nishida J, McCuskey RS, McDonnell D, and Fox ES. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol Gastrointest Liver Physiol 267: G1135-G1141, 1994.
124. Nishimura Y, Takei Y, Kawano S, Goto M, Nagano K, Tsuji S, Nagai H, Ohmae A, Fusamoto H, and Kamada T. The F(ab′)2 fragment of an anti-ICAM-1 monoclonal antibody attenuates liver injury after orthotopic liver transplantation. Transplantation 61: 99-104, 1996.
125. Okuaki Y, Miyazaki H, Zeniya M, Ishikawa T, Ohkawa Y, Tsuno S, Sakaguchi M, Hara M, Takahashi H, and Toda G. Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver 16: 188-194, 1996.
126. Ozaki M, Deshpande SS, Angkeow P, Bellan J, Lowenstein CJ, Dinauer MC, Goldschmidt-Clermont PJ, and Irani K. Inhibition of the Racl GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. FASEB J 14: 418-429, 2000.
127. Peralta C, Bartrons R, Serafin A, Blazquez C, Guzman M, Prats N, Xaus C, Cutillas B, Gelpi E, and Rosello-Catafau J. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 34: 1164-1173, 2001.
128. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, and Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine. Hepatology 25: 934-937, 1997.
129. 2 receptors. Hepatology 29: 126-132, 1999.
130. Qian T, Nieminen AL, Herman B, and Lemasters JJ. Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol Cell Physiol 273: C1783-C1792, 1997.
131. Redaelli CA, Tian YH, Schaffner T, Ledermann M, Baer HU, and Dufour JF. Extended preservation of rat liver graft by induction of heme oxygenase-1. Hepatology 35: 1082-1092, 2002.
132. Rensing H, Jaeschke H, Bauer I, Patau C, Datene V, Pannen BH, and Bauer M. Differential activation pattern of redox-sensitive transcription factors and stress-inducible dilator systems heme oxygenase-1 and inducible nitric oxide synthase in hemorrhagic and endotoxic shock. Crit Care Med 29: 1962-1971, 2001.
133. Rentsch M, Post S, Palma P, Lang G, Menger MD, and Messmer K. Anti-ICAM-1 blockade reduces postsinusoidal WBC adherence following cold ischemia and reperfusion, but does not improve early graft function in rat liver transplantation. J Hepatol 32: 821-828, 2000.
134. Ricciardi R, Foley DP, Quarfordt SH, Saavedra JE, Keefer LK, Wheeler SM, Donohue SE, Callery MP, and Meyers WC. V-PYRRO/NO: An hepato-selective nitric oxide donor improves porcine liver hemodynamics and function after ischemia reperfusion. Transplantation 71: 193-198, 2001.
135. Rivera-Chavez FA, Toledo-Pereyra LH, Dean RE, Crouch L, and Ward PA. Exogenous and endogenous nitric oxide but not iNOS inhibition improves function and survival of ischemically injured livers. J Invest Surg 14: 267-273, 2001.
136. 2-release by activated Kupffer cells upon hypoxia-reoxygenation. Am J Physiol Gastrointest Liver Physiol 261: G602-G607, 1991.
137. Sawaya DE, Zibari GB, Minardi A, Bilton B, Burney D, Granger DN, McDonald JC, and Brown M. P-selectin contributes to the initial recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. Shock 12: 227-232, 1999.
138. Schultz RM, Marder P, Spaethe SM, Herron DK, and Sofia MJ. Effects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and superoxide production. Prostaglandins Leukot Essent Fatty Acids 43: 267-271, 1991.
139. Scoazec JY, Borghi-Scoazec G, Durand F, Bernuau J, Pham BN, Belghiti J, Feldmann G, and Degott C. Complement activation after ischemia-reperfusion in human liver allografts: Incidence and pathophysiological relevance. Gastroenterology 112: 908-918, 1997.
140. Scoazec JY, Durand F, Degott C, Delautier D, Bernuau J, Belghiti J, Benhamou JP, and Feldmann G. Expression of cytokine-dependent adhesion molecules in postreperfusion biopsy specimens of liver allografts. Gastroenterology 107: 1094-1102, 1994.
141. Shappell SB, Toman C, Anderson DC, Taylor AA, Entman ML, and Smith CW. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol 144: 2702-2711, 1990.
142. Shen XD, Ke B, Zhai Y, Amersi F, Gao F, Anselmo DM, Busuttil RW, and Kupiec-Weglinski JW. CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Transplantation 74: 315-319, 2002.
143. Simonet WS, Hughes TM, Nguyen HQ, Trebasky LD, Danilenko DM, and Medlock ES. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest 94: 1310-1319, 1994.
144. Squadrito GL and Pryor WA. Oxidative chemistry of nitric oxide: The role of superoxide, peroxynitrite and carbon dioxide. Free Radic Biol Med 25: 392-403, 1998.
145. Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, and Wonigeit K. Expression pattern of leukocyte adhesion ligand molecules on human liver endothelia. Am J Pathol 142: 481-488, 1993.
146. Straatsburg IH, Boermeester MA, Wolbink GJ, van Gulik TM, Gouma DJ, Frederiks WM, and Hack CE. Complement activation induced by ischemia-reperfusion in humans: A study in patients undergoing partial hepatectomy. J Hepatol 32: 783-791, 2000.
147. Strasberg SM. Preservation injury and donor selection: It all starts here. Liver Transpl Surg 5, Suppl 1: S1-S7, 1997.
148. Suzuki S and Toledo-Pereyra LH. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 57: 253-258, 1994.
149. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, and Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 55: 1265-1272, 1993.
150. Takada Y, Boudjema K, Jaeck D, Bel-Haouari M, Doghmi M, Chenard MP, Wolf P, and Cinqualbre J. Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation. Transplantation 59: 10-16, 1995.
151. Teoh N, Dela Pena A, and Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry. Hepatology 36: 94-102, 2002.
152. Thiemermann C, Ruetten H, Wu CC, and Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845-2851, 1995.
153. Thompson RC and Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 83: 6692-6696, 1986.
154. Uchinami H, Yamamoto Y, Kume M, Yonezawa K, Ishikawa Y, Taura K, Nakajima A, Hata K, and Yamaoka Y. Effect of heat shock preconditioning on NF-kappaB/I-kappaB pathway during I/R injury of the rat liver. Am J Physiol Gastrointest Liver Physiol 282: G962-G971, 2002.
155. Vollmar B, Glasz J, Leiderer R, Post S, and Menger MD. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145: 1421-1431, 1994.
156. Vollmar B, Glasz J, Menger MD, and Messmer K. Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 117: 195-200, 1995.
157. Vollmar B, Menger MD, Glasz J, Leiderer R, and Messmer K. Impact of leukocyte-endothelial interaction in hepatic ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 267: G786-G783, 1994.
158. Vollmar B, Richter S, and Menger MD. Leukocyte stasis in hepatic sinusoids. Am J Physiol Gastrointest Liver Physiol 270: G798-G803, 1996.
159. Walcher F, Marzi I, Fischer R, Bauer M, and Larsen R. Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation. J Surg Res 61: 244-249, 1996.
160. Wang Y, Lawson JA, and Jaeschke H. Differential effect of 2-aminoethyl-isothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion injury and endotoxemia. Shock 10: 20-25, 1998.
161. Wang Y, Mathews WR, Guido DM, Farhood A, and Jaeschke H. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock 4: 282-288, 1995.
162. Wang Y, Vodovotz Y, Kim PK, Zamora R, and Billiar TR. Mechanisms of hepatoprotection by nitric oxide. Ann NY Acad Sci 962: 415-422, 2002.
163. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 320: 365-376, 1989.
164. Wheeler MD, Katuna M, Smutney OM, Froh M, Dikalova A, Mason RP, Samulski RJ, and Thurman RG. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum Gene Ther 12: 2167-2177, 2001.
165. Wiest R and Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough. Hepatology 35: 478-491, 2002.
166. Witthaut R, Farhood A, Smith CW, and Jaeschke H. Complement and tumor necrosis factor-α contribute to Mac-1 (CD11b/CD18) upregulation and systemic neutrophil activation during endotoxemia in vivo. J Leukoc Biol 55: 105-111, 1994.
167. Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL, and Kubes P. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest 99: 2782-2790, 1997.
168. Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, and Hashida M. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther 298: 894-899, 2001.
169. Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, and Clavien PA. P-selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 29: 1494-1502, 1999.
170. Yin DP, Sankary HN, Chong AS, Ma LL, Shen J, Foster P, and Williams JW. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 66: 152-157, 1998.
171. Yokoyama Y, Baveja R, Sonin N, Nakanishi K, Zhang JX, and Clemens MG. Altered endothelin receptor subtype expression in hepatic injury after ischemia/reperfusion. Shock 13: 72-78, 2000.
172. Yonezawa K, Yamamoto Y, Yamamoto H, Ishikawa Y, Uchinami H, Taura K, Nakajima A, and Yamaoka Y. Suppression of tumor necrosis factor-alpha production and neutrophil infiltration during ischemia-reperfusion injury of the liver after heat shock preconditioning. J Hepatol 35: 619-627, 2001.
173. Yoshidome H, Kato A, Edwards MJ, and Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor kappaB. Hepatology 30: 203-208, 1999.
174. Yoshidome H, Kato A, Miyazaki M, Edwards MJ, and Lentsch AB. IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. Am J Pathol 155: 1059-1064, 1999.
175. Zhang B, Borderie D, Sogni P, Soubrane O, Houssin D, and Calmus Y. NO-mediated vasodilation in the rat liver. Role of hepatocytes and liver endothelial cells. J Hepatol 26: 1348-1355, 1997.
176. Zhang P, Xie M, Zagorski J, and Spitzer JA. Attenuation of hepatic neutrophil sequestration by anti-CINC antibody in endotoxic rats. Shock 4: 262-268, 1995.
177. Zhou W, McCollum MO, Levine BA, and Olson MS. Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology 16: 1236-1240, 1992.
178. Zhou W, Zhang Y, Hosch MS, Lang A, Zwacka RM, and Engelhardt JF. Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion. Hepatology 33: 902-914, 2001.
179. Zou XM, Yagihashi A, Hirata K, Tsuruma T, Matsuno T, Tarumi K, Asanuma K and Watanabe N. Downregulation of cytokine-induced neutrophil chemoattractant and prolongation of rat liver allograft survival by interleukin-10. Surg Today 28: 184-191, 1998.
180. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, and Engelhardt JF. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 100: 279-289, 1997.
181. Zwacka RM, Zhou W, Zhang Y, Darby CJ, Dudus L, Halldorson J, Oberley L, and Engelhardt JF. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nat Med 4: 698-704, 1998.